Research Article
The Relationship between ALA16VAL Single Gene Polymorphism and Renal Cell Carcinoma
Table 3
Distribution of Mn-SOD (Ala16Val) polymorphism in patients with RCC and controls.
| Mn-SOD | Patients
| Control
| | OR (95% CI) |
| Mn-SOD | | | 0.05 | | ALA16VAL | | | | | Ala/Ala | 14 [34%] | 8 [16%] | | | Ala/Val | 17 [42%] | 19 [38%] | | | Val/Val | 10 [24%] | 23 [46%] | | | (Ala/Ala + Ala/val) | 31 [76%] | 27 [54%] | | 2.64 (1.06–6.69) | Val/Val | 10 [24%] | 23 [46%] | | | Allele frequency | | | | 2.26 (1.24–4.12) | Ala | 45 [55%] | 35 [35%] | | | Val | 37 [45%] | 65 [65%] | | |
|
|
There was statistically significant difference between groups.
|